Literature DB >> 15054474

Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Ursula F Bailer1, Julie C Price, Carolyn C Meltzer, Chester A Mathis, Guido K Frank, Lisa Weissfeld, Claire W McConaha, Shannan E Henry, Sarah Brooks-Achenbach, Nicole C Barbarich, Walter H Kaye.   

Abstract

Several lines of evidence suggest that a disturbance of serotonin neuronal pathways may contribute to the pathogenesis of anorexia nervosa (AN) and bulimia nervosa (BN). This study applied positron emission tomography (PET) to investigate the brain serotonin 2A (5-HT(2A)) receptor, which could contribute to disturbances of appetite and behavior in AN and BN. To avoid the confounding effects of malnutrition, we studied 10 women recovered from bulimia-type AN (REC AN-BN, > 1 year normal weight, regular menstrual cycles, no binging, or purging) compared with 16 healthy control women (CW) using PET imaging and a specific 5-HT(2A) receptor antagonist, [18F]altanserin. REC AN-BN women had significantly reduced [18F]altanserin binding potential relative to CW in the left subgenual cingulate, the left parietal cortex, and the right occipital cortex. [18F]altanserin binding potential was positively related to harm avoidance and negatively related to novelty seeking in cingulate and temporal regions only in REC AN-BN subjects. In addition, REC AN-BN had negative relationships between [18F]altanserin binding potential and drive for thinness in several cortical regions. In conclusion, this study extends research suggesting that altered 5-HT neuronal system activity persists after recovery from bulimia-type AN, particularly in subgenual cingulate regions. Altered 5-HT neurotransmission after recovery also supports the possibility that this may be a trait-related disturbance that contributes to the pathophysiology of eating disorders. It is possible that subgenual cingulate findings are not specific for AN-BN, but may be related to the high incidence of lifetime major depressive disorder diagnosis in these subjects. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054474      PMCID: PMC4301578          DOI: 10.1038/sj.npp.1300430

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  118 in total

Review 1.  Eating disorders: progress and problems.

Authors:  B T Walsh; M J Devlin
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

2.  Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat.

Authors:  B E Summer; G Fink
Journal:  J Steroid Biochem Mol Biol       Date:  1995-07       Impact factor: 4.292

Review 3.  The serotonin system and aggressive personality disorder.

Authors:  L Siever; R L Trestman
Journal:  Int Clin Psychopharmacol       Date:  1993-11       Impact factor: 1.659

4.  [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.

Authors:  P W Burnet; S L Eastwood; P J Harrison
Journal:  Neurochem Int       Date:  1997-06       Impact factor: 3.921

5.  Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients.

Authors:  E A Osuch; T A Ketter; T A Kimbrell; M S George; B E Benson; M W Willis; P Herscovitch; R M Post
Journal:  Biol Psychiatry       Date:  2000-11-15       Impact factor: 13.382

Review 6.  The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.

Authors:  L C Barr; W K Goodman; L H Price; C J McDougle; D S Charney
Journal:  J Clin Psychiatry       Date:  1992-04       Impact factor: 4.384

7.  The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.

Authors:  D Attar-Lévy; J L Martinot; J Blin; M H Dao-Castellana; C Crouzel; B Mazoyer; M F Poirier; M C Bourdel; N Aymard; A Syrota; A Féline
Journal:  Biol Psychiatry       Date:  1999-01-15       Impact factor: 13.382

8.  Disturbed body image in patients with eating disorders.

Authors:  R L Horne; J C Van Vactor; S Emerson
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

9.  5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.

Authors:  Cristina Messa; Cristina Colombo; Rosa Maria Moresco; Clara Gobbo; Laura Galli; Giovanni Lucignani; Maria Carla Gilardi; Giovanna Rizzo; Enrico Smeraldi; Raffaella Zanardi; Francesc Artigas; Ferruccio Fazio
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

10.  Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study.

Authors:  Cesar R Skaf; Airton Yamada; Griselda E J Garrido; Carlos A Buchpiguel; Sergio Akamine; Claudio C Castro; Geraldo F Busatto
Journal:  J Affect Disord       Date:  2002-04       Impact factor: 4.839

View more
  33 in total

Review 1.  Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Authors:  Timothy D Brewerton
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Altered interoceptive activation before, during, and after aversive breathing load in women remitted from anorexia nervosa.

Authors:  L A Berner; A N Simmons; C E Wierenga; A Bischoff-Grethe; M P Paulus; U F Bailer; A V Ely; W H Kaye
Journal:  Psychol Med       Date:  2017-07-17       Impact factor: 7.723

Review 3.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

Review 4.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

5.  Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling.

Authors:  Patrick M Fisher; Carolyn C Meltzer; Julie C Price; Rhaven L Coleman; Scott K Ziolko; Carl Becker; Eydie L Moses-Kolko; Sarah L Berga; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2009-03-25       Impact factor: 5.357

6.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

7.  Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Laurel Chiappetta; Neale Scott Mason; Carl Becker; Julie C Price
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

Review 8.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

9.  Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Authors:  Ursula F Bailer; Guido K Frank; Julie C Price; Carolyn C Meltzer; Carl Becker; Chester A Mathis; Angela Wagner; Nicole C Barbarich-Marsteller; Cinnamon S Bloss; Karen Putnam; Nicholas J Schork; Anthony Gamst; Walter H Kaye
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

10.  An Association Study of the A218C Polymorphism of the Tryptophan Hydroxylase 1 Gene with Eating Disorders in a Korean Population: A Pilot Study.

Authors:  Youl-Ri Kim; Jong-Min Woo; Si Young Heo; Jeong Hyun Kim; Soo-Jin Lim; Bum-Hee Yu
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.